Quarterly report pursuant to Section 13 or 15(d)

Temporary Equity and Stockholders' Deficiency (Details Narrative)

v3.20.2
Temporary Equity and Stockholders' Deficiency (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 28, 2020
Sep. 02, 2020
Feb. 18, 2020
Sep. 30, 2020
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Sep. 03, 2020
Common stock, shares authorized       150,000,000       150,000,000   150,000,000 150,000,000
Number of shares issued, value       $ 1,201,200 $ 1,600,950 $ 2,125,000 $ 884,750        
Foreign currency translation adjustments       (17,837) 365,350     $ 400,686 $ 730,767    
Options [Member]                      
Number of stock options to purchase of shares granted               1,535,000      
Share based compensation       56,413 105,178     $ 262,670 $ 331,680    
Employee service share-based compensation, nonvested awards, compensation not yet recognized, stock options       $ 862,823       $ 862,823      
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition               2 years 7 months 28 days      
Number of stock options outstanding       9,209,586       9,209,586   9,550,640  
2018 Plan [Member]                      
Number of stock options to purchase of shares granted 1,535,000                    
Options exercise price $ 0.605                    
Vesting percentage 25.00%                    
Stock option vesting period 3 years                    
Number of stock option granted, value $ 263,642                    
Weighted average estimated fair value of the stock options granted               $ 0.17 $ 0.13    
2018 GGI Options [Member]                      
Number of stock options outstanding       2,280,000       2,280,000      
One Year Warrant [Member]                      
Number of warrants to purchase common stock       7,653,276       7,653,276      
Exercise price of warrants       $ 0.34       $ 0.34      
Series B Preferred Stock [Member]                      
Shares issued, price per share       $ 10       $ 10      
Cumulative cash dividends annual rate               8.00%      
Dividends earned       $ 181,281 $ 181,746     $ 540,217 $ 539,311    
Dividends payable       $ 82,772       82,772      
Preferred stock, amount of cumulative dividends in arrears               $ 1,804,578   $ 1,264,361  
Investors [Member]                      
Number of shares issued   3,706,805           413,530      
Number of shares issued for sales       3,532,941       3,532,941      
Number of shares issued for sales, value       $ 1,201,200       $ 1,201,200      
Number of shares issued, value               $ 140,600      
Exercise price of warrants       $ 0.34       $ 0.34      
Shareholder [Member] | Series B Preferred Stock [Member]                      
Number of shares repurchased     1,600                
Shares issued, price per share     $ 10                
Payment of accrued dividends     $ 2,451                
Employees [Member]                      
Number of stock options to purchase of shares granted 1,135,000                    
Board of Directors [Member]                      
Number of stock options to purchase of shares granted 300,000                    
Consultants [Member]                      
Number of stock options to purchase of shares granted 100,000